Back to compounds

COMPOUND PROFILE / SMALL MOLECULES

Enobosarm / Ostarine.

Research draft

Enobosarm, also called Ostarine, is a selective androgen receptor modulator, not a peptide.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

Enobosarm, also called Ostarine, is a selective androgen receptor modulator, not a peptide.

CLASSIFICATIONSmall molecules
MOLECULAR / SEQUENCE INFONot specified
PRIMARY CONTEXTCompound

Mechanism

It activates androgen-receptor pathways relevant to muscle and other tissues.

Human research

Randomised muscle-wasting and cancer-development studies exist; they do not establish safe performance use.

Preclinical & other research

Experimental work examined tissue selectivity and anabolic responses.

Safety & unknowns

Liver and hormonal risks are important; selective activity is not risk-free.

Regulatory status

Investigational in the reviewed clinical contexts; performance-market availability is not approval.

Reported use & evidence

Research profile draft

The supplied Enobosarm / Ostarine profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds